Abstract:Objective: The role of C-X-C motif chemokine 12 (CXCL12) in atherosclerotic cardiovascular diseases (ASCVDs) has emerged as one of the research hotspots in recent years. Studies reported that the higher blood CXCL12 level was associated with increased major adverse cardiovascular events (MACEs), but the results were inconsistent. The objective of this study was to clarify the prognostic value of the blood CXCL12 level in patients with coronary artery disease (CAD) through meta-analysis. Methods: All related studies about the association between the blood CXCL12 level and the prognosis of CAD were comprehensively searched and screened according to inclusion criteria and exclusion criteria. The quality of the included literature was evaluated using the Newcastle-Ottawa Scale (NOS). The heterogeneity test was conducted, and the pooled hazard risk (HR) or the odds ratio (OR) with a 95% confidence interval (CI) was calculated using the fixed-effect or random-effects model accordingly. Publication bias was evaluated using Begg's funnel plot and Egger's test. Sensitivity analysis and subgroup analysis were also conducted. Results: A total of 12 original studies with 2,959 CAD subjects were included in the final data combination. The pooled data indicated a significant association between higher CXCL12 levels and MACEs both in univariate analysis (HR 5.23, 95% CI 2.48–11.04) and multivariate analysis (HR 2.53, 95% CI 2.03–3.16) in the CXCL12 level as the category variable group. In the CXCL12 level as the continuous variable group, the result also indicated that the higher CXCL12 level significantly predicted future MACEs (multivariate OR 1.55, 95% CI 1.02–2.35). Subgroup analysis of the CXCL12 level as the category variable group found significant associations in all acute coronary syndrome (ACS) (univariate HR 9.72, 95% CI 4.69–20.15; multivariate HR 2.47, 95% CI 1.79–3.40), non-ACS (univariate HR 2.73, 95% CI 1.65–4.54; multivariate HR 3.49, 95% CI 1.66–7.33), Asian (univariate HR 7.43, 95% CI 1.70–32.49; multivariate HR 2.21, 95% CI 1.71–2.85), Caucasian (univariate HR 3.90, 95% CI 2.73–5.57; multivariate HR 3.87, 95% CI 2.48–6.04), short-term (univariate HR 9.36, 95% CI 4.10–21.37; multivariate HR 2.72, 95% CI 1.97–3.76), and long-term (univariate HR 2.86, 95% CI 1.62–5.04; multivariate HR 2.38, 95% CI 1.76–3.22) subgroups. Subgroup analysis of the CXCL12 level as the continuous variable group found significant associations in non-ACS (multivariate OR 1.53, 95% CI 1.23–1.92), Caucasian (multivariate OR 3.83, 95% CI 1.44–10.19), and long-term (multivariate OR 1.62, 95% CI 1.37–1.93) subgroups, but not in ACS (multivariate OR 1.36, 95% CI 0.67–2.75), Asian (multivariate OR 1.40, 95% CI 0.91–2.14), and short-term (multivariate OR 1.16, 95% CI 0.28–4.76) subgroups. No significant publication bias was found in this meta-analysis. Conclusion: The higher blood CXCL12 level is associated with increased MACEs in patients with CAD, and the blood CXCL12 level may serve as an important prognostic index for CAD. Integrating the blood CXCL12 level into CAD risk assessment tools may provide more comprehensive messages for evaluating and managing patients with CAD.

Alteration and clinical significance of CXCL16 in patients with coronary heart disease

Chemokine CXCL16 Expression in Serum of Patients with Coronary Artery Disease

Association Between Non-High-density Lipoprotein Cholesterol and Coronary Artery Disease in Patients with Acute Coronary Syndrome: a Single-Centre Retrospective Cross-Sectional Analysis

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

The Changes of Secretory Type Ⅱ Phospholipase A2 in Coronary Heart Disease and Its Relationship with High Sensifive-C Reactive Protein

CXC chemokine ligand 16 as a prognostic marker in patients with intermediate coronary artery lesions: a 2-year follow-up study.

Correlations of chemokine CXCL16 and TNF-α with coronary atherosclerotic heart disease

Levels of Serum Cystatin C and IL-6 and Its Clinical Significance in Patients with Acute Coronary Syndrome

Changes of the serum high-sensitivity C-reactive protein and uric acid level in male patients with coronary heart disease and its clinical significance

The role of blood CXCL12 level in prognosis of coronary artery disease: A meta-analysis

Changes in Serum Vascular Cell Adhesion Molecules and C-reactive Protein in Patients with Acute Coronary Syndrome

High-Sensitivity CRP is Independently Associated with HDL-Mediated Cholesterol Efflux Capacity and HDL Remodeling in Patients with Coronary Artery Disease

Clinical study on relationship of hs-CRP level with presence and prognosis of cardiac dys-function in patients with type 2 diabetes after percutaneous coronary intervention

Long-term Prognostic Value of High-Sensitivity C-reactive Protein and Its Combination with Serum Cholesterol in Acute Coronary Syndrome

The Changes of the Levels of Plasma Oxidized Low Density Lipoprotein, High-Sensitivity C-Reactive Protein and its Relation to the Endothelial Injury in Patients with Acute Coronary Syndrome

Correlation of Plasma Hs-Crp Level with the Severity and Prognosis of Coronary Artery Disease in 667 Patients

An Intron Polymorphism in the CXCL16 Gene is Associated with Increased Risk of Coronary Artery Disease in Chinese Han Population: a Large Angiography-Based Study.

The Variation and Significance of Plasma Hs-Crp,il-6 and Sil-6R Levels in Coronary Heart Disease Patients

Clinical study of correlation between plasma homocysteine (Hcy)、hypersensitive C-reactive protein(hs-CRP) and coronary heart disease(CHD)

Clinical significance of change of various indexes levels in patients with coronary heart disease complicating chronic chro-nic heart failure

Prognostic Value of Highly Sensitive C-Reactive Protein and Plaque Morphology in Coronary Artery Disease in China.